| Name | Title | Contact Details |
|---|
L&T Technology Services Limited (LTTS) is a global leader in Engineering and R&D (ER&D) services. With 816 patents filed for 57 of the Global Top 100 ER&D spenders, LTTS lives and breathes engineering and technology. Our innovations speak for themselves – World`s 1st Autonomous Welding Robot, Solar `Connectivity` Drone, and the Smartest Campus in the World, to name a few. LTTS` expertise in engineering design, product development, smart manufacturing, and digitalization touches every area of our lives - from the moment we wake up to when we go to bed. With 79 Innovation and R&D design centers globally, we specialize in disruptive technology spaces such as EACV, Med Tech, 5G, AI and Digital Products, Digital Manufacturing, and Sustainability. LTTS is a publicly listed subsidiary of Larsen & Toubro Limited, the $21 billion Indian conglomerate operating in over 30 countries.
Adapdix Corporation, the digital transformation leader in Edge AI automation and control software. Company provides innovative software platform for enterprises that optimizes Artificial Intelligence (AI) and Machine Learning (ML) at the edge. Its customer-centric EdgeOps ML platform increases uptime of equipment, reduces supply chain and logistics cost and increases remote worker productivity. Adapdix software automates operational and business decisions reliably in real-time and allows scaling of AI technologies across the enterprise. The company has launched its products at leading industrial firms and OEM/machine equipment partners, contributing significant operational improvements.
TechNosis is a Appleton, WI-based company in the Computers and Electronics sector.
Saama develops life science solutions that accelerate clinical and commercial development. Today, more than 50 biotech companies – including many of the top 20 pharmaceutical companies – use Saama`s award-winning Life Science Analytics Cloud (LSAC) platform to accelerate more than 1,500 studies, including the clinical trial led to the world`s first COVID-19 vaccine. LSAC`s rich applications facilitate unprecedented and authoritative oversight and automation of comprehensive clinical research data, enabling companies to file New Drug Application (NDAs) more efficiently and bring treatments to patients sooner.